SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors

Authors

Zhongwu Li, Peking University
Jing Yuan, The Chinese PLA General Hospital
Lixin Wei, The Chinese PLA General Hospital
Kaiyong Mei, Guangzhou Medical University
Junqiu Yue, Hubei Cancer Hospital
Hongwen Gao, Jilin University
Miao Zhang, Peking University
Ling Jia, Peking University
Qiang Kang, Peking University
Xiaozheng Huang, Peking University
Dengfeng Cao, Washington University School of Medicine in St. Louis

Journal

International Journal of Clinical and Experimental Pathology

Publication Date

2015

Volume

8

Issue

6

Inclusive Pages

7072-7082

Document Type

Open Access Publication

Rights and Permissions

Dengfeng Cao, et al. SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors. International Journal of Clinical and Experimental Pathology. 2015 Jun 1;8(6): 7072-82. www.ijcep.com /ISSN:1936-2625/IJCEP0008056.

Recommended Citation

Li, Zhongwu; Yuan, Jing; Wei, Lixin; Mei, Kaiyong; Yue, Junqiu; Gao, Hongwen; Zhang, Miao; Jia, Ling; Kang, Qiang; Huang, Xiaozheng; and Cao, Dengfeng, "SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors." International Journal of Clinical and Experimental Pathology. 8, 6. 7072-7082. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4361